Trial Profile
Phase II trial of tedalinab.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2008
Price :
$35
*
At a glance
- Drugs Tedalinab (Primary)
- Indications Musculoskeletal pain; Neuropathic pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Glenmark Pharmaceuticals Ltd
- 18 Jul 2008 New trial record.